Long-term mortality and causes of death in endoscopically verified upper gastrointestinal bleeding: comparison of bleeding patients and population controls

• Published in: Scandinavian journal of gastroenterology Vol. 52; no. 11; p. 1211
• Main Authors: Miilunpohja, S, Jyrkkä, J, Kärkkäinen, J M, Kastarinen, H, Heikkinen, M, Paajanen, H, Rantanen, T, Hartikainen, Jek
• Format: Journal Article
• Language: English
• Published: England 02.11.2017
• Subjects: Aged; Aged, 80 and over; Case-Control Studies; Cause of Death; Comorbidity; Endoscopy; Female; Finland; Gastrointestinal Hemorrhage - diagnosis; Gastrointestinal Hemorrhage - mortality; Hospital Mortality; Hospitalization - statistics & numerical data; Humans; Male; Middle Aged; Retrospective Studies; Survival Analysis; Tertiary Care Centers; Upper gastrointestinal bleeding; long-term mortality; cause of death; comorbidity; survival; bleeding complications
• ISSN: 1502-7708
• DOI: 10.1080/00365521.2017.1347811

Upper gastrointestinal bleeding (UGIB) is a common emergency, with in-hospital mortality between 3 and 14%. However, the long-term mortality and causes of death are unknown. We investigated the long-term mortality and causes of death in UGIB patients in a retrospective single-centre case-control study design. A total of 569 consecutive patients, aged ≥18 years, admitted to Kuopio University Hospital for their first endoscopically verified UGIB during the years 2009-2011 were identified from hospital records. For each UGIB patient, an age, sex and hospital district matched control patient was identified from the Statistics Finland database. Data on endoscopy procedures, laboratory values, comorbidities and medication were obtained from patient records. Data on deaths and causes of death were obtained from Statistics Finland. In-hospital mortality of UGIB patients was low at 3.3%. The long-term (mean follow-up 32 months) mortality of UGIB patients was significantly higher than controls (34.1 versus 12.1%, p < .001). During the 6 months following UGIB, the risk of death compared to controls was highest (HR 19.2, 95% CI 7.0-52.4, p < .001) and remained higher up to 3 years after the bleeding. Beyond 3 years' follow-up, there was no difference in mortality between the groups (HR 0.7, 95% CI 0.4-1.6, p = .436). During the first 3 months after the UGIB episode, mortality was related to gastrointestinal diseases; after 3 months, the causes of death were related to comorbidities and did not differ from causes of death in controls. UGIB patients have three times higher long-term mortality than population controls.